Assessment of safety and tolerability of remogliflozin etabonate (GSK189075) when administered with total daily dose of 2000 mg of metformin

• Main Authors: Robert Dobbins (Author), Elizabeth K. Hussey (Author), Robin O'Connor-Semmes (Author), Susan Andrews (Author), Wenli Tao (Author), William O. Wilkison (Author), Bentley Cheatham (Author), Katare Sagar (Author), Barkate Hanmant (Author)
• Format: Book
• Published: BMC, 2021-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Patients with type 2 diabetes mellitus (T2DM) are characterized by an elevated glycemic index and are at a higher risk for complications such as cardiovascular disease, nephropathy, retinopathy and peripheral neuropathy. Normalization of glycemic index can be achieved by dosing c...